Arcutis Biotherapeutics, Inc. (ARQT) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 3.08B USD. 52-week range 19.30 to 31.77 USD. Trailing P/E 111.3. Data as of 2026-10-09.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known ...